behaelterbau

Sterile tank

Mobile processing equipment for vaccine production

Our small and medium-sized sterile mixing tanks have been used by national and overseas pharmaceutical companies for decades. Our sterile tanks are used by renowned, leading pharmaceutical companies, producers of generic medicines and subcontractors. Our sterile tanks are easy to clean, have a compact design and feature innovative engineering. As an established supplier for the pharmaceuticals industry, we have numerous references when it comes to tanks for stirring and mixing sterile products.
ansatzanlage1

Articles in the range Sterile tank

IMG_5121
Biotechnology Chemical industry Pharmaceutical

Process tank for sterile production

Pharmaceutical process tank for the sterile production of serum pursuant to PED 2014/68/EU cat. 4/module G, ATEX Directive 2014/34/EU and MD 2006/42/EU.
Top section as pressure dome cover with welded conical nozzle. Torispherical base design. The tank is equipped with a control system, analysis technology and filter. The tank is equipped with a heating/cooling jacket and insulation cover.
Equipment also includes:
  • Magnetic stirrer for a viscosity of 250 mPas
  • Filter for sterile filtration
  • pH measurement
  • O² measurement
  • Metaglas sight glass
  • LED sight glass lights
  • D-ended sight glass in casing
  • Rupture disc / safety valve
  • Product tubes
  • CIP-compatible sampling and outlet valve
  • CIP cleaning nozzle
  • ATEX design
  • Control cabinet in line with ATEX
AREA OF APPLICATION:
Industry: Pharmaceutical
Cytostatic drugs, serum production
SIZE:
10l – 800l
OPERATING DATA:
Tank product chamber:
p = -0,5 / +3,5 bar,
t = -10 / +150 °C
Double wall:
p = -0,5 / +4,5 bar,
t = -10 / +150 °C
MATERIAL:
Parts in contact with product 1.4539 , Delta ferrite <1%, with APZ 3.2/3.1 AD 2000, Ra <0.8µm
Request article
Configure article
cip2
Biotechnology Cosmetics industry

CIP tanks with insulating material

Pharmaceutical mixing and process tank for CIP liquids pursuant to PED 2014/68/EU based on module G.
Upper section with folding dome pressure cover and welded conical nozzle. Torispherical base design.

The tank is equipped with a heating/cooling jacket and insulation cover.

Equipment also includes:
  • Magnetic stirrer as a bottom agitator for a viscosity of 100 mPas
  • Metaglas sight glass
  • LED sight glass lights
  • Rupture disc / safety valve
  • Product tubes
  • CIP cleaning nozzle
AREA OF APPLICATION:
Industry: pharmaceutical, food industry
Product: Cleaning liquids, demineralised water
SIZE:
500 l – 4.000 l
OPERATING DATA:
Tank product chamber:
p = -1 / +3 bar,
t = -10 / +150 °C
Double wall:
p = -1 / +3,5 bar,
t = -10 / +150 °C
MATERIAL:
Parts in contact with product 1.4404/ 1.4435/ 316L , with APZ 3.1 AD 2000, Ra <0.5µm
Request article
Configure article
IST_800_0_steril_waegezellen
Chemical industry Pharmaceutical

800 l sterile tank with load cells

Item-Nr.: n.N.
Pharmaceutical mixing and processing tank for the sterile production of serum. Conformity pursuant to PED 2014/68/EU Cat. 4/Module G and MD 2006/42/EU.
Top section as pressure dome cover with welded conical TC nozzle. Torispherical base design. The tank is equipped with a control system, analysis and weighing technology. The tank is equipped with a heating/cooling jacket and insulation cover.
Equipment also includes:
  • Magnetic stirrer for a viscosity of 250 mPas
  • pH measurement
  • O² measurement
  • Metaglas sight glass
  • LED sight glass lights
  • D-ended sight glass in casing
  • Rupture disc / safety valve
  • Product tubes
  • CIP-compatible sampling and outlet valve
  • CIP cleaning nozzle
  • Load cells
  • IRIS monitoring
AREA OF APPLICATION:
Industry: Pharmaceutical
Product: Vaccine, serum production
SIZE:
10 l – 1.000 l
OPERATING DATA:
Tank product chamber:
p = -1 / +3 bar,
t = -10 / +150 °C
Double wall:
p = -1 / +4 bar,
t = -10 / +150 °C
MATERIAL:
Product wetted parts 1.4435, Delta Ferrite <3%, with APZ 3.1 AD 2000, Ra <0,3µm
Request article
Configure article

Company

portfolio

links

Dear Sir or Madam,
Dear Mr Weinert,
27.04.2021


On April 30, 2021, we will open another site at Allergopharma GmbH & Co. KG in Reinbek to support COVID 19 vaccine production in the presence of Federal Minister Spahn and Minister President Günther. We would have been pleased to invite you to this opening.

Unfortunately, this was not possible due to the pandemic.
We would therefore like to take this opportunity to thank you for your extraordinary commitment to supplying equipment at short notice to support vaccine production. Allergopharma, as part of Dermapharm Holding SE, is now a further partner in the Europe-wide production network for the vaccine of BioNTech and Pfizer. This network now comprises more than a dozen important pharmaceutical manufacturers and suppliers. From now on, one of four production steps will take place in Reinbek: the vaccine formulation. This is where our mRNA active ingredient is combined with the lipids. A protective shell is created around the mRNA and the vaccine can reach its target in the body to induce the necessary immune response.


Your company has made a very important contribution to the global pandemic response with great know-how and under incredible time pressure. We would like to express our sincere thanks to you and your team! Without their commitment, the successful completion of the project would not have been possible.
We look forward to working with you in partnership in the future!

Dr. Hans-Georg Feldmeier – CEO Dermapharm SE
Dr. Sierk Poetting – CFO and COO BioNTech SE